Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update
Indexed incrossref
Abstract
Purpose To update the ASCO guideline for antiemetics in oncology. Methods ASCO convened an Expert Panel and conducted a systematic review of the medical literature for the period of November 2009 to June 2016. Results Forty-one publications were included in this systematic review. A phase III randomized controlled trial demonstrated that adding olanzapine to antiemetic prophylaxis reduces the likelihood of nausea among adult patients who are treated with high emetic risk antineoplastic agents. Randomized controlled trials also support an expanded role for neurokinin 1 receptor antagonists in patients who are treated with chemotherapy. Recommendation Key updates include the addition of olanzapine to antiemetic…
Citation impact
629
total citations
- FWCI
- 75.30
- Percentile
- 100%
- References
- 110
Citations per year
Authors
17Topics & keywords
Topics
Keywords
- Medicine
- Aprepitant
- Antiemetic
- Nausea
- Vomiting
- Carboplatin
- Chemotherapy-induced nausea and vomiting
- Guideline
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.